The heart is an early target of anthrax lethal toxin in mice: A protective role for neuronal Nitric Oxide Synthase (nNOS)

PLoS Pathogens

Volumn 5, Issue 5, 2009, Pages

  Moayeri, Mahtab ^a   Crown, Devorah ^a   Dorward, David W ^b   Gardner, Don ^b   Ward, Jerrold M ^a   Li, Yan ^c   Cui, Xizhong ^c   Eichacker, Peter ^c   Leppla, Stephen H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; ALLOPURINOL; ANTHRAX TOXIN; CARBOXY 2 PHENYL 4,4,5,5, TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID BINDING PROTEIN; IMIDAZOLINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOGLOBIN; NEURONAL NITRIC OXIDE SYNTHASE; SCAVENGER; SODIUM NITRITE; TROPONIN I; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL TOXIN; NOS1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; ELECTRON MICROSCOPY; ENZYME DEFICIENCY; FEMALE; HEART; HEART CONTRACTION; HEART EJECTION FRACTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOPATHOLOGY; MACROPHAGE; MICROSCOPY; MITOCHONDRION; MORTALITY; MOUSE; MUSCLE CELL; MYOFILAMENT; NEURONAL NITRIC OXIDE SYNTHASE DEFICIENCY; NONHUMAN; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; TISSUE DEGENERATION; TREATMENT FAILURE; VASCULAR NECROSIS; WILD TYPE; ANIMAL; HEART MUSCLE; HEART MUSCLE CELL; HEART STROKE VOLUME; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VIROLOGY;

ANIMALIA; MUS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HEART; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE I; STROKE VOLUME;

EID: 67249104566     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000456     Document Type: Article

References (80)

1. Leppla SH (2006) Bacillus anthracis toxins. In: Alouf JE, Popoff MR, eds. The Comprehensive Sourcebook of Bacterial Protein Toxins. Burlington, MA: Academic Press. pp 323-347.
2. Moayeri M, Martinez NW, Wiggins J, Young HA, Leppla SH (2004) Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect Immun 72: 4439-4447. (Pubitemid 38989300)
3. Moayeri M, Haines D, Young HA, Leppla SH (2003) Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 112: 670-682. (Pubitemid 38057708)
4. Gupta PK, Moayeri M, Crown D, Fattah RJ, Leppla SH (2008) Role of N-terminal amino acids in the potency of anthrax lethal factor. PLoS ONE 3: e3130. doi:10.1371/journal.pone.0003130.
5. Ezzell JW, Ivins BE, Leppla SH (1984) Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect Immun 45: 761-767. (Pubitemid 14066198)
6. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, et al. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280: 734-737. (Pubitemid 28243347)
7. Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352 Pt 3: 739-745. (Pubitemid 32015030)
8. Kalns J, Scruggs J, Millenbaugh N, Vivekananda J, Shealy D, et al. (2002) TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection. Biochem Biophys Res Commun 292: 41-44.
9. Cui X, Moayeri M, Li Y, Li X, Haley M, et al. (2004) Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol 286: R699-R709. (Pubitemid 38375001)
10. Raines KW, Kang TJ, Hibbs S, Cao GL, Weaver J, et al. (2006) Importance of nitric oxide synthase in the control of infection by Bacillus anthracis. Infect Immun 74: 2268-2276.
11. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, Montecucco C (2000) Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. Int J Med Microbiol 290: 421-427. (Pubitemid 30805558)
12. Kuo SR, Willingham MC, Bour SH, Andreas EA, Park SK, et al. (2008) Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb Pathog 44: 467-472.
13. Gozes Y, Moayeri M, Wiggins JF, Leppla SH (2006) Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect Immun 74: 1266-1272. (Pubitemid 43185566)
14. Cui X, Besch V, Khaibullina A, Hergen A, Quezado M, et al. (2007) Neuronal nitric oxide synthase deficiency decreases survival in bacterial peritonitis and sepsis. Intensive Care Med 33: 1993-2003. (Pubitemid 47632272)
15. Razavi HM, Hamilton JA, Feng Q (2005) Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 106: 147-162. (Pubitemid 40613056)
16. Andreka P, Tran T, Webster KA, Bishopric NH (2004) Nitric oxide and promotion of cardiac myocyte apoptosis. Mol Cell Biochem 263: 35-53. (Pubitemid 39256144)
17. Ward ME, Toporsian M, Scott JA, Teoh H, Govindaraju V, et al. (2005) Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J Clin Invest 115: 3128-3139. (Pubitemid 41567577)
18. Comini L, Boraso A, Bachetti T, Bernocchi P, Pasini E, et al. (2005) Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes. Pharmacol Res 51: 409-417. (Pubitemid 40326192)
19. Casadei B (2006) The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 91: 943-955. (Pubitemid 44690806)
20. Loyer X, Samuel JL, Heymes C (2005) Cardiac myocyte neuronal nitric oxide synthase. New therapeutic target in heart failure? Arch Mal Coeur Vaiss 98: 1244-1248.
21. Sears CE, Ashley EA, Casadei B (2004) Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philos Trans R Soc Lond B Biol Sci 359: 1021-1044.
22. Plebani M, Zaninotto M (1998) Diagnostic strategies in myocardial infarction using myoglobin measurement. Eur Heart J 19 Suppl N: N12-N15. (Pubitemid 28524044)
23. O'Brien PJ (2008) Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology 245: 206-218.
24. O'Brien PJ (2006) Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev Mol Diagn 6: 685-702. (Pubitemid 44525595)
25. Babuin L, Jaffe AS (2005) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173: 1191-1202. (Pubitemid 41637819)
26. O'Brien PJ, Smith DE, Knechtel TJ, Marchak MA, Pruimboom-Brees I, et al. (2006) Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim 40: 153-171.
27. Colli A, Josa M, Pomar JL, Mestres CA, Gherli T (2007) Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today? Cardiology 108: 4-10.
28. Alhadi HA, Fox KA (2004) Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 97: 187-198. (Pubitemid 38489158)
29. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, et al. (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416: 337-339. (Pubitemid 34260250)
30. Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, et al. (2003) Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92: e52-e59.
31. Ashley EA, Sears CE, Bryant SM, Watkins HC, Casadei B (2002) Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 105: 3011-3016. (Pubitemid 34693835)
32. Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, et al. (2003) Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92: 1322-1329. (Pubitemid 36773474)
33. Sweeney D, Cui X, Solomon S, Subramanian M, Li Y, et al. (2008) Anthrax edema and lethal toxins produce very different patterns of cardiovascular dysfunction in canines. Am J Respir Crit Care Med 177: A115.
34. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555: 589-606. (Pubitemid 38404582)
35. Harrison R (2004) Physiological roles of xanthine oxidoreductase. Drug Metab Rev 36: 363-375. (Pubitemid 38802492)
36. Zhang GX, Kimura S, Murao K, Shimizu J, Matsuyoshi H, et al. (2008) Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation. Cardiovasc Res 81: 389-399.
37. Kinugawa S, Huang H, Wang Z, Kaminski PM, Wolin MS, et al. (2005) A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ Res 96: 355-362. (Pubitemid 40279910)
38. Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, et al. (2004) Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A 101: 15944-15948. (Pubitemid 39507906)
39. Kittleson MM, Hare JM (2005) Xanthine oxidase inhibitors: an emerging class of drugs for heart failure. Eur Heart J 26: 1458-1460. (Pubitemid 41373485)
40. Boueiz A, Damarla M, Hassoun PM (2008) Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am J Physiol Lung Cell Mol Physiol 294: L830-L840.
41. Sinha SS, Shiva S, Gladwin MT (2008) Myocardial protection by nitrite: evidence that this reperfusion therapeutic will not be lost in translation. Trends Cardiovasc Med 18: 163-172.
42. Dezfulian C, Raat N, Shiva S, Gladwin MT (2007) Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 75: 327-338. (Pubitemid 46961934)
43. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, et al. (2007) Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204: 2089-2102. (Pubitemid 47360871)
44. Kevil CG, Patel RP (2008) Preserving vessel function during ischemic disease: new possibilities of inorganic nitrite therapy. Expert Rev Cardiovasc Ther 6: 1175-1179.
45. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, et al. (2001) Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61: 6649-6655. (Pubitemid 32896479)
46. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, et al. (2001) Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 114: 2755-2773. (Pubitemid 32785455)
47. Liu S, Wang H, Currie BM, Molinolo A, Leung HJ, et al. (2008) Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem 283: 529-540.
48. Kirby JE (2004) Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun 72: 430-439. (Pubitemid 38018204)
49. Pandey J, Warburton D (2004) Knock-on effect of anthrax lethal toxin on macrophages potentiates cytotoxicity to endothelial cells. Microbes Infect 6: 835-843. (Pubitemid 39055544)
50. Warfel JM, Steele AD, D'Agnillo F (2005) Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 166: 1871-1881. (Pubitemid 40734409)
51. Watson LE, Kuo SR, Katki K, Dang T, Park SK, et al. (2007) Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS ONE 2: e466. doi:10.1371/journal.pone.0000466.
52. Sherer K, Li Y, Cui X, Li X, Subramanian M, et al. (2007) Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit Care Med 35: 1560-1567. (Pubitemid 46809321)
53. Cui X, Li Y, Moayeri M, Choi GH, Subramanian GM, et al. (2005) Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. J Infect Dis 191: 422-434. (Pubitemid 40139768)
54. Mungrue IN, Bredt DS (2004) nNOS at a glance: implications for brain and brawn. J Cell Sci 117: 2627-2629. (Pubitemid 38997246)
55. Lim G, Venetucci L, Eisner DA, Casadei B (2008) Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling. Cardiovasc Res 77: 256-264. (Pubitemid 351197636)
56. Loyer X, Heymes C, Samuel JL (2008) Constitutive nitric oxide synthases in the heart from hypertrophy to failure. Clin Exp Pharmacol Physiol 35: 483-488. (Pubitemid 351326784)
57. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, et al. (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271: 22810-22814. (Pubitemid 26304729)
58. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96: 657-662. (Pubitemid 29061264)
59. Seddon M, Shah AM, Casadei B (2007) Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 75: 315-326. (Pubitemid 46961933)
60. Damy T, Ratajczak P, Shah AM, Camors E, Marty I, et al. (2004) Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363: 1365-1367. (Pubitemid 38529877)
61. Damy T, Ratajczak P, Robidel E, Bendall JK, Oliviero P, et al. (2003) Upregulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 17: 1934-1936.
62. Bendall JK, Damy T, Ratajczak P, Loyer X, Monceau V, et al. (2004) Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 110: 2368-2375. (Pubitemid 39407341)
63. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S, et al. (2005) nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112: 3729-3737. (Pubitemid 43739513)
64. Stoyanovsky D, Murphy T, Anno PR, Kim YM, Salama G (1997) Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21: 19-29. (Pubitemid 27092227)
65. Zahradnikova A, Minarovic I, Venema RC, Meszaros LG (1997) Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 22: 447-454. (Pubitemid 28051053)
66. Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, et al. (2007) Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100: e32-e44. (Pubitemid 46272417)
67. Loyer X, Gomez AM, Milliez P, Fernandez-Velasco M, Vangheluwe P, et al. (2008) Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117: 3187-3198.
68. Vandsburger MH, French BA, Helm PA, Roy RJ, Kramer CM, et al. (2007) Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur Heart J 28: 2792-2798. (Pubitemid 350135526)
69. Brown GC, Borutaite V (2007) Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75: 283-290. (Pubitemid 46961922)
70. Kline DD, Yang T, Huang PL, Prabhakar NR (1998) Altered respiratory responses to hypoxia in mutant mice deficient in neuronal nitric oxide synthase. J Physiol 511(Pt 1): 273-287. (Pubitemid 28421330)
71. Tsutsui M (2004) Neuronal nitric oxide synthase as a novel anti-atherogenic factor. J Atheroscler Thromb 11: 41-48.
72. Morishita T, Tsutsui M, Shimokawa H, Horiuchi M, Tanimoto A, et al. (2002) Vasculoprotective roles of neuronal nitric oxide synthase. FASEB J 16: 1994-1996.
73. Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM (2008) Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation 117: 1991-1996. (Pubitemid 351543475)
74. Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91: 776-781. (Pubitemid 35285074)
75. Nakata S, Tsutsui M, Shimokawa H, Tamura M, Tasaki H, et al. (2005) Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK/ERK pathway. Arterioscler Thromb Vasc Biol 25: 2502-2508. (Pubitemid 43732270)
76. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, et al. (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5: 320-326. (Pubitemid 29124369)
77. Knowlton KU (2008) CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol 323: 315-335.
78. Badorff C, Fichtlscherer B, Rhoads RE, Zeiher AM, Muelsch A, et al. (2000) Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. Circulation 102: 2276-2281. (Pubitemid 30808019)
79. Kim J, Park H, Chang M, Han SH, Chung H, et al. (2008) The effects of anthrax lethal factor on the macrophage proteome: Potential activity on nitric oxide synthases. Arch Biochem Biophys 472: 58-64.
80. Varughese M, Chi A, Teixeira AV, Nicholls PJ, Keith JM, et al. (1998) Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol Med 4: 87-95. (Pubitemid 28223948)